Financhill
Back

Medpace Holdings, Inc. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Buy
60

MEDP
Medpace Holdings, Inc.

Last Price:
$569.15
Seasonality Move:
-3.36%
Buy
64

LYEL
Lyell Immunopharma, Inc.

Last Price:
$37.17
Seasonality Move:
-16.78%
Buy
60
Medpace Holdings, Inc. (MEDP) is a Buy

Is Medpace Holdings, Inc. a Buy, Sell or Hold?

  • The current Medpace Holdings, Inc. [MEDP] share price is $571.53. The Score for MEDP is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • MEDP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MEDP Stock Price Chart

What is Medpace Holdings, Inc.'s stock price today?

  • The Medpace Holdings, Inc. share price today is $571.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MEDP is experiencing buying pressure, which is a positive indicator for future bullish movement.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $37.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.

MEDP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.96 Sell
Relative Strength Index (14 RSI): 51.64 Buy
Chaikin Money Flow: 123675 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (554.01 - 595.55) Sell
Bollinger Bands (100): (474.44 - 581.7) Buy

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.08 Buy
Relative Strength Index (14 RSI): 79.16 Buy
Chaikin Money Flow: -97373 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.11 - 32.35) Buy
Bollinger Bands (100): (10.77 - 23.75) Buy

MEDP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 562.39 Buy
20-day SMA: 571.18 Buy
50-day SMA: 573.88 Sell
200-day SMA: 423.17 Buy
8-day EMA: 563.98 Buy
20-day EMA: 567.81 Buy
50-day EMA: 560.25 Buy
200-day EMA: 464.32 Buy

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.51 Buy
20-day SMA: 28.33 Buy
50-day SMA: 21.67 Buy
200-day SMA: 13.52 Buy
8-day EMA: 33.02 Buy
20-day EMA: 28.99 Buy
50-day EMA: 23.45 Buy
200-day EMA: 17.42 Buy

Medpace Holdings, Inc. Earnings Growth & MEDP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.95 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.83 per share, and an increase next year of $1.40 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

Medpace Holdings, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):